Jon Banas
Analyst · Imperial Capital. Please go ahead
Thanks, Jeff, and good morning, everyone. In the next few slides, I will cover the details of our quarterly and full year financial results, put some context around some of the key items that impacted our earnings, and then provide some color on our balance sheet and liquidity, before talking about expectations for 2022. On Slide 8, we show a summary of our results for the fourth quarter and full year 2021, with comparisons to the prior year. Fourth quarter 2021 sales totaled $601.3 million, down 14% versus the fourth quarter of 2020. The decline was the result of lower volume and mix in all our automotive segments, as the semiconductor shortage and other supply chain issues continued to weigh on vehicle production. The volume and mix impact was partially offset by some positive customer price adjustments, in part related to our material recovery initiatives. From a more positive perspective, fourth quarter sales were an improvement of 14% when compared sequentially to the third quarter of this year. We were encouraged by the increasing production volume and improved stability in schedules that we saw in the latter part of the fourth quarter, and we are cautiously optimistic that these positive trends will continue. Adjusted EBITDA for the fourth quarter 2021 was $2 million or 0.3% of sales, compared to $57 million or 8.2% of sales in the fourth quarter of 2020. The year-over-year decline was driven primarily by increased material costs, the previously mentioned unfavorable volume and mix, higher wages, and general inflationary pressure across the board. Positive customer price adjustments were only a small offset to the inflation and volume pressures. On a sequential basis, we saw strong improvement of E36 million in adjusted EBITDA versus the third quarter of this year, an indication of how we are leveraging both the increased sales, as well as our ongoing cost improvements. on a US GAAP basis, we incurred a net loss of $102 million in the fourth quarter. This included certain non-cash asset impairments, non-cash valuation allowances established on net deferred tax assets. Excluding these and other smaller special items, we incurred an adjusted net loss of $50.3 million or $2.94 per diluted share for the fourth quarter of 2021. This compared to adjusted net income of $3.3 million, or $0.19 per diluted share in the fourth quarter of 2020. And sequentially, adjusted debt loss improved by 53%. For the full year 2021, our sales totaled $2.33 billion, a decrease of 1.9% versus 2020. The main driver of the decline was a divestiture of certain European operations in our India business on July 1st of 2020, as well as unfavorable volume and mix. These negative factors were partially offset by favorable foreign exchange benefiting the topline. Adjusted EBITDA for the year came in at negative $8 million compared to positive $35.7 million in 2020. Again, the key driver was significantly higher material costs, higher wages, and general inflation. Unfavorable volume and mix and the non-recurrence of certain COVID-related government assistance, also contributed to the decline. These negative factors were only partially offset by improved operating efficiency, lower SGA&E expenses, and the other cost saving and lean initiatives we have been executing. Full year net loss was $322.8 million, which included non-cash asset impairments, deferred tax asset valuation allowances, restructuring charges, and other special items. Adjusted for the net impact of these items, we incurred a net loss for the year of $222 million or $13.04 per diluted share. From a CapEx perspective, we ended the year at $96 million, or 4.1% of sales. This compared to CapEx of $91.8 million or 3.9% of sales in 2020, with the increase primarily related to higher program launches. Moving to Slide 9. The charts on Slide 9 quantify the significant drivers of the year-over-year changes in our sales and adjusted EBITDA for the fourth quarter. For sales, unfavorable volume and mix, net of customer price adjustments, reduced sales by $93 million. FX was a further negative impact of $3 million during the quarter. For adjusted EBITDA, lower SGA&E expense was a positive variance of $12 million compared to the prior year, and savings from restructuring initiatives added $5 million. These improvements were more than offset by $15 million of unfavorable volume and mix net of price adjustments, $30 million in increased material costs, and $26 million from wage increases, general inflation, and other items. Moving to Slide 10, for the full year, unfavorable volume and mix net of customer price adjustments, reduced our sales by $31 million. Divestitures further reduced sales by $65 million. Favorable foreign exchange was a positive partial offset of $50 million. For full year adjusted EBITDA, a number of positive factors benefited results, including $33 million from improved operating efficiencies, $32 million from lower SGA&E expense, and $16 million in savings from earlier restructuring initiatives. But these improvements were more than offset by $64 million in higher material costs, $41 million in higher wages and general inflation, $15 million related to the discontinuation of COVID-related benefits, and $7 million of unfavorable volume and mix. Moving to Slide 11. In terms of free cash flow, we experienced a modest outflow of $24 million in a quarter, essentially in line with our expectations. Our teams did an outstanding job of reducing inventory in our plans as production schedules began to stabilize, and of collecting and tooling receivables from our customers. This helped to keep net cash used in operations at just $4 million in the quarter, despite rising sequential sales. In addition, our continued focus on conserving cash, resulted in CapEx coming in at just $20 million, which was lower than what we had expected heading into the quarter. With cash on hand of $248 million, and an additional $148 million of availability on our revolver, we ended the year with total liquidity of $396 million. Given our outlook for improving industry trends and our successful execution of ongoing cost reduction initiatives, we believe this certainly provides adequate capital for the funding needs of the company. Turning to Slide 12. On this slide, we provide our initial guidance for 2022, along with our expectations for regional light vehicle production that forms the basis of our annual plan. For this year, we expect sales in the range of $2.6 billion to $2.8 billion, and adjusted EBITDA in the range of $50 million to $60 million. We believe these estimates are appropriately conservative, given the continuing uncertainties within our industry, and the macroeconomic trends in each of our key operating regions. We will continue to invest in our business conservatively in 2022, with CapEx expected to be in the range of $90 million to 100 million, which is similar to 2021. As a percentage of sales, this would put us at less than 4%, so continuing modest investment in the business, primarily to fund growth on our new customer programs. Cash restructuring in 2022 is estimated at $20 million to 30 million. The majority of this investment will be focused on further right-sizing of our operations and overhead in Europe, consistent with our driving value initiatives. The restructuring investment is expected to have a payback period ranging between one and two years. Finally, as reflected on our balance sheet at December 31, we anticipate receiving a tax refund of more than $50 million in 2022 related to prior year US income tax returns, Net of ongoing cash tax payment requirements, we expect a net cash tax refund of $30 million to 40 million for the year, which will further strengthen our already solid liquidity position. Moving to Slide 13. The chart on Slide 13 provides some additional detail around the main positive and negative factors impacting our 2022 adjusted EBITDA outlook. These are broad estimates based on current market conditions and our own assumptions for the remainder of the year, and reflect the midpoint of the adjusted EBITDA range we provided. We expect volume and mix, including customer price adjustments, to drive $130 million of improvement in 2022. The positive impacts of our cost recovery initiatives are also included here. With improving volume, we also expect to drive significant improvements in manufacturing efficiencies, adding approximately $70 million in adjusted EBITDA for the year. These anticipated gains in efficiency should be more than enough to offset expected increase in general and wage inflation, and even the planned normalization of incentive compensation in 2022. However, we still face an expected $70 million in incremental headwinds from material cost inflation this year that won't be covered through improved operational efficiencies. As mentioned earlier, we believe our initial guidance is appropriately conservative, given the uncertainties in the marketplace. Further, with recent announcements from some of our customers delaying production and continuing supply chain challenges, we believe such conservatism is warranted. We are factoring in the recovery of a fair or share of the higher material costs, but there are no guarantees on the level of recovery we will ultimately achieve. On the other hand, there is potentially some upside opportunity if production volumes come back stronger than expected in the back half of the year, or if material costs unexpectedly begin to moderate. Finally, let me emphasize that we believe we are in very good shape from a liquidity perspective. We have a solid cash balance, along with an undrawn revolving credit facility, and we anticipate sizable cash inflows from not only the tax refund, but also a sale lease-back of a non-core property to further bolster our cash balance during the year. As a result, we expect to have more than sufficient resources to continue our focus on growing our topline, expanding margins, and working with our customers to ensure that we're being fairly compensated for the cost and value of the products we supply. Based on the November 2023 maturity of our term loan B, we will likely be in the market later this year to refinance that tranche of debt. With a maturity date in 2024, the paydown of our senior secured notes is less of a priority at this point. That concludes my prepared comments, so let me turn the call back to Jeff.